Variability of core microbiota in newly diagnosed treatment-naïve paediatric Inflammatory Bowel Disease patients
Authors:
Preprint
Abstract
BACKGROUND & AIMS: Intestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naïve) IBD, in comparison to healthy paediatric controls (HC). METHODS: In this prospective study, performed at two tertiary centres, faecal samples from newly diagnosed, treatment-naïve paediatric IBD patients were collected prior to bowel cleansing for colonoscopy (t0) and 1, 3 and 6 weeks and 3 months after initiation of therapy. The microbial profiles of Crohn’s disease (CD) and Ulcerative colitis (UC) patients were compared with HC and linked to therapeutic response. Microbiota composition was analysed by IS-pro technology. RESULTS: Microbial profiles of 104 new IBD-patients (63 CD, 41 UC, median age 14.0 years) were compared to 61 HC (median 7.8 years). IBD was mainly characterised by decreased abundance of Alistipes finegoldi and Alistipes putredinis , which characterize a healthy state microbial core. The classifier including these core species as predictors achieved an AUC of the ROC curve of .87. Core bacteria tended to regain abundance during treatment, but did not reach healthy levels. CONCLUSION: Faecal microbiota profiles of children with de novo CD and UC can be discriminated from HC with high accuracy, mainly driven by a decreased abundance of species shaping the microbial core in the healthy state. Paediatric IBD can therefore be characterized by decreased abundance of certain bacterial species reflecting the healthy state rather than by the introduction of pathogens.Keywords
All Related Versions
- Published version: PLOS ONE, 13 (8), e0197649.
This publication has 45 references indexed in Scilit:
- Understanding and Preventing the Global Increase of Inflammatory Bowel DiseaseGastroenterology, 2017
- The Human Intestinal Microbiome in Health and DiseaseNew England Journal of Medicine, 2016
- The Gut Microbiome of Pediatric Crohnʼs Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune ResponseInflammatory Bowel Diseases, 2016
- Rising incidence of pediatric inflammatory bowel disease in Scotland*Inflammatory Bowel Diseases, 2012
- Role of the microbiota in inflammatory bowel diseasesInflammatory Bowel Diseases, 2012
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic ReviewGastroenterology, 2012
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trendsInflammatory Bowel Diseases, 2011
- Microbiota in Pediatric Inflammatory Bowel DiseaseThe Journal of Pediatrics, 2010
- Rising Incidence of Inflammatory Bowel Disease Among Children: A 12‐year StudyJournal of Pediatric Gastroenterology and Nutrition, 2010